Haematologica, Vol 93, Issue 1, 132-136 doi:10.3324/haematol.11694
Copyright © 2008 by Ferrata Storti Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Fernandez et al. - Additional Figure
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fernàndez, V.
Right arrow Articles by Campo, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fernàndez, V.
Right arrow Articles by Campo, E.

Chronic Lymphocytic Leukemia

Gene expression profile and genomic changes in disease progression of early-stage chronic lymphocytic leukemia

Verònica Fernàndez1, Pedro Jares2, Itziar Salaverria1, Eva Giné3, Sílvia Beà1, Marta Aymerich1, Dolors Colomer1, Neus Villamor1, Francesc Bosch3, Emili Montserrat3, Elias Campo1,

1 Hematopathology Section, Department of Pathology
2 Genomics Unit and
3 Department of Hematology, Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain

Correspondence: Elias Campo, Hematopathology Unit, Hospital Clínic, Villarroel 170, 08036 Barcelona, Spain. E-mail: ecampo{at}clinic.ub.es

The biologic mechanisms involved in the clinical progression from early stages of patients with chronic lymphocytic leukemia (CLL) are not well known. We investigated sequential samples from 16 untreated CLL patients obtained at diagnosis in early stage and after progression before treatment. One patient had a p16 INK4a homozygous deletion at diagnosis and progression, and 3 patients acquired a p53 mutation, gains of 5q21-q23 and 11pter-p14, and a gain of chromosome 12 respectively, during the progression of the disease. Gene expression profile analysis showed a significant modulation of 58 genes with a particular downregulation of genes that are inhibitors of cell adhesion and motility.

Key words: chronic lymphocytic leukemia, progression, microarrays, comparative genomic hybridization.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
A. Navarro, S. Bea, V. Fernandez, M. Prieto, I. Salaverria, P. Jares, E. Hartmann, A. Mozos, A. Lopez-Guillermo, N. Villamor, et al.
MicroRNA Expression, Chromosomal Alterations, and Immunoglobulin Variable Heavy Chain Hypermutations in Mantle Cell Lymphomas
Cancer Res., September 1, 2009; 69(17): 7071 - 7078.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
V. Grubor, A. Krasnitz, J. E. Troge, J. L. Meth, B. Lakshmi, J. T. Kendall, B. Yamrom, G. Alex, D. Pai, N. Navin, et al.
Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (ROMA)
Blood, February 5, 2009; 113(6): 1294 - 1303.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Guarini, S. Chiaretti, S. Tavolaro, R. Maggio, N. Peragine, F. Citarella, M. R. Ricciardi, S. Santangelo, M. Marinelli, M. S. De Propris, et al.
BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgVH unmutated chronic lymphocytic leukemia (CLL) cells
Blood, August 1, 2008; 112(3): 782 - 792.
[Abstract] [Full Text] [PDF]